logo-loader
viewInovio Pharmaceuticals Inc

Inovio starts recruiting for first MERS vaccine test in humans

Since 2012, MERS has infected over 1,600 people, with almost 600 deaths

lungs.jpg
MERS attacks the lungs, and has so far been affected patients in more than 21 countries across the world

Inovio Pharmaceuticals (NASDAQ:INO) has kicked-off the recruitment process for its collaborative vaccine study for Middle East Respiratory Syndrome (MERS).

Along with GeneOne Life Science, the firm is co-developing its vaccine GLS-5300, with the trial set to make it the first MERS vaccine to be tested in humans.

The trial is in partnership with the Walter Reed Army Institute of Research (WRAIR) in Maryland, where it is being conducted.

Joseph Kim, president and chief executive, said, “After partnering with WRAIR and receiving an IND approval from the FDA late last year, we are pleased to now open this trial with our collaborators.”

MERS attacks the lungs, and has so far been affected patients in more than 21 countries across the world, including the US, the UK and a number of countries in the Middle East.

“The MERS virus has triggered widespread outbreaks and deaths in the Middle East and Korea and the healthcare community is urgently exploring possible preventive and therapeutic solutions.”

Since 2012, MERS has infected over 1,600 people, with almost 600 deaths, a mortality rate of about 40%.

Last year, GLS-5300 produced 100% protection from a live version of the virus in a rhesus macaque non-human primate study.

The first-in-man phase I trial will provide Inovio with safety and immunogenicity data, the firm said.

Quick facts: Inovio Pharmaceuticals Inc

Price: 14.785 USD

NASDAQ:INO
Market: NASDAQ
Market Cap: $2.48 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Auryn Resources spins our Peruvian assets creating a new company called Fury...

Auryn Resources (TSE: AUG- NYSEAMERICAN: AUG) Executive Chairman Ivan Bebek and new company Fury Gold Mines CEO Mike Timmins joined Steve Darling from Proactive Vancouver with news Auryn is creating a new gold-focused exploration and development company called Fury Gold Mines. Bebek discusses...

20 hours, 15 minutes ago

2 min read